Carlyle
Latest statistics and disclosures from Carlyle Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QDEL, ZI, MKSI, VTRU, GDS, and represent 89.07% of Carlyle Group's stock portfolio.
- Added to shares of these 10 stocks: PCVX (+$72M), VRNA (+$49M), HLVX (+$30M), VERA (+$23M), PHAT (+$21M), JSPR (+$16M), INVH (+$15M), RPHM (+$12M), ACET (+$12M), SPRB (+$6.4M).
- Started 19 new stock positions in CBAY, NCNA, HLVX, JSPR, MTEM, AGLE, PCVX, EFTR, SPRB, XCUR. SLNO, ACET, PHAT, INVH, Sientra, RPHM, VRNA, PRTK, VERA.
- Reduced shares in these 2 stocks: 1life Healthcare (-$228M), SPNT.
- Sold out of its positions in 1life Healthcare, SPNT.
- Carlyle Group was a net buyer of stock by $47M.
- Carlyle Group has $3.4B in assets under management (AUM), dropping by -2.47%.
- Central Index Key (CIK): 0001527166
Tip: Access up to 7 years of quarterly data
Positions held by Carlyle consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Carlyle Group
Carlyle Group holds 30 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Quidel Corp (QDEL) | 33.1 | $1.1B | 13M | 89.09 |
|
|
| ZoomInfo Technologies Common Stock (ZI) | 27.0 | $906M | 37M | 24.71 |
|
|
| MKS Instruments (MKSI) | 22.4 | $752M | 8.5M | 88.62 |
|
|
| Vitru Ord (VTRU) | 4.2 | $142M | 6.2M | 22.76 |
|
|
| GDS Hldgs Sponsored Ads (GDS) | 2.3 | $76M | +7% | 4.1M | 18.66 |
|
| Vaxcyte (PCVX) | 2.2 | $72M | NEW | 1.9M | 37.48 |
|
| Getty Images Holdings Cl A Com (GETY) | 1.8 | $61M | 12M | 5.09 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 1.5 | $49M | NEW | 2.5M | 20.08 |
|
| Hillevax (HLVX) | 0.9 | $30M | NEW | 1.8M | 16.37 |
|
| Vera Therapeutics Cl A (VERA) | 0.7 | $23M | NEW | 3.0M | 7.73 |
|
| Phathom Pharmaceuticals (PHAT) | 0.6 | $21M | NEW | 2.9M | 7.11 |
|
| Jasper Therapeutics (JSPR) | 0.5 | $16M | NEW | 8.8M | 1.80 |
|
| Invitation Homes (INVH) | 0.4 | $15M | NEW | 478k | 31.23 |
|
| Reneo Pharmaceuticals (RPHM) | 0.4 | $12M | NEW | 2.1M | 5.90 |
|
Setup an alertCarlyle will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Adicet Bio (ACET) | 0.4 | $12M | NEW | 2.1M | 5.75 |
|
| Life Storage Inc reit (LSI) | 0.3 | $11M | 86k | 131.09 |
|
|
| Cubesmart (CUBE) | 0.3 | $10M | 221k | 46.22 |
|
|
| Seacor Marine Hldgs (SMHI) | 0.3 | $10M | +9% | 1.3M | 7.61 |
|
| Spruce Biosciences (SPRB) | 0.2 | $6.4M | NEW | 2.9M | 2.21 |
|
| Smart Sh Global Ads (EM) | 0.2 | $5.3M | 4.8M | 1.11 |
|
|
| Nucana Sponsored Adr (NCNA) | 0.1 | $3.2M | NEW | 3.3M | 0.96 |
|
| Paratek Pharmaceuticals (PRTK) | 0.1 | $2.6M | NEW | 1.0M | 2.52 |
|
| Soleno Therapeutics (SLNO) | 0.1 | $2.5M | NEW | 1.2M | 2.11 |
|
| Effector Therapeutics (EFTR) | 0.1 | $1.7M | NEW | 4.8M | 0.35 |
|
| Cymabay Therapeutics (CBAY) | 0.0 | $1.1M | NEW | 131k | 8.73 |
|
| Meta Data Sponsored Ads (AIU) | 0.0 | $329k | 314k | 1.05 |
|
|
| Sientra | 0.0 | $256k | NEW | 167k | 1.53 |
|
| Exicure Com New (XCUR) | 0.0 | $242k | NEW | 282k | 0.86 |
|
| Molecular Templates (MTEM) | 0.0 | $75k | NEW | 200k | 0.38 |
|
| Aeglea Biotherapeutics (AGLE) | 0.0 | $69k | NEW | 241k | 0.29 |
|
Past Filings by Carlyle Group
SEC 13F filings are viewable for Carlyle Group going back to 2012
- Carlyle Group 2023 Q1 filed May 5, 2023
- Carlyle Group 2022 Q4 filed Feb. 10, 2023
- Carlyle Group 2022 Q3 filed Nov. 10, 2022
- Carlyle Group 2022 Q2 filed Aug. 12, 2022
- Carlyle Group 2022 Q1 filed May 13, 2022
- Carlyle Group 2021 Q4 filed Feb. 11, 2022
- Carlyle Group 2021 Q3 filed Nov. 12, 2021
- Carlyle Group 2021 Q2 filed Aug. 12, 2021
- Carlyle Group 2021 Q1 filed May 14, 2021
- Carlyle Group 2020 Q4 filed Feb. 12, 2021
- Carlyle Group 2020 Q3 filed Nov. 13, 2020
- Carlyle Group 2020 Q2 filed Aug. 13, 2020
- Carlyle Group 2020 Q1 filed May 13, 2020
- Carlyle Group 2019 Q4 filed Feb. 13, 2020
- Carlyle Group 2019 Q3 filed Nov. 13, 2019
- Carlyle Group 2019 Q2 filed Aug. 13, 2019